コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ng who should be offered surgery (unilateral adrenalectomy).
2 ts, an additional 7.7% subsequently required adrenalectomy.
3 ents were between 3 months and 10 years post-adrenalectomy.
4 s following surgery from causes unrelated to adrenalectomy.
5 ic structures and organs before laparoscopic adrenalectomy.
6 Two patients (9.1%) were converted to open adrenalectomy.
7 erm complications related to hypertension or adrenalectomy.
8 ts with MEN 2 (33%); three of them underwent adrenalectomy.
9 the risk for tumor recurrence after partial adrenalectomy.
10 and 20 patients who had undergone bilateral adrenalectomy.
11 lateral and one patient underwent unilateral adrenalectomy.
12 pepcan-12, as shown by its marked loss after adrenalectomy.
13 ll transplants survived indefinitely despite adrenalectomy.
14 5 percent) of the patients who had undergone adrenalectomy.
15 ss in those patients undergoing laparoscopic adrenalectomy.
16 itioning episode also negated the effects of adrenalectomy.
17 ic adrenalectomy required conversion to open adrenalectomy.
18 onditioning might resemble those produced by adrenalectomy.
19 HEA) produced the same pattern of results as adrenalectomy.
20 ients undergoing either laparoscopic or open adrenalectomy.
21 re being employed, particularly laparoscopic adrenalectomy.
22 periodic primary aldosteronism were cured by adrenalectomy.
23 nt with medications, radiation, or bilateral adrenalectomy.
24 -adrenoreceptor blockade with propranolol or adrenalectomy.
25 tions, pituitary radiation, and/or bilateral adrenalectomy.
26 equire more frequent follow-up for NOD after adrenalectomy.
27 s and this is at least partially reversed by adrenalectomy.
28 ival after either adrenal-sparing surgery or adrenalectomy.
29 rogenesis did not show protective effects of adrenalectomy.
30 control the adrenal vein during laparoscopic adrenalectomy.
31 s treated with or without LND during primary adrenalectomy.
32 CNS IL-1beta-induced atrophy is abrogated by adrenalectomy.
33 hypertensive medications is difficult before adrenalectomy.
34 or complete resolution of hypertension after adrenalectomy.
35 ovides equivalent oncologic outcomes to open adrenalectomy.
36 ective advantages compared with laparoscopic adrenalectomy.
37 th 19 patients who underwent open unilateral adrenalectomies.
38 he hormone with surgical and pharmacological adrenalectomies.
39 rming posterior retroperitoneal and subtotal adrenalectomies.
43 35 consecutive patients before laparoscopic adrenalectomy, 3D volume-rendered CT scans were created
45 s that this day-specific fever is blocked by adrenalectomy accompanied by constant low corticosterone
46 s were assigned to one of four groups: SHAM, adrenalectomy, adrenalectomy + Ang II (25 ng/min, subcut
47 (IMCD) subsegments from rats that underwent adrenalectomy, adrenalectomy plus replacement with a phy
50 in both FF and RF rats, depletion of CORT by adrenalectomy (ADX) did not significantly influence the
53 rthermore, previous studies demonstrate that adrenalectomy (ADX) leads to a reduction in OT receptors
54 ol (2 g/kg) or saline to rats that underwent adrenalectomy (ADX) or received sham surgery and perform
55 ucocorticoids, male rats underwent bilateral adrenalectomy (ADX) or sham surgery, and were killed aft
56 ucocorticoids, male rats underwent bilateral adrenalectomy (ADX) or sham surgery, and were killed aft
61 chniques to determine the effects of chronic adrenalectomy (ADX), low basal (CT) and high (HCT) corti
62 er the age of a cell affects its response to adrenalectomy (ADX), the numbers of dentate gyrus cells
65 elevated by IS in intact subjects, although adrenalectomy, ADX (with basal corticosterone replacemen
69 Systolic BP in adrenalectomy + Ang II and adrenalectomy + ALDO (238 +/- 8 and 241 +/- 9 mmHg, resp
70 omy + Ang II (25 ng/min, subcutaneously), or adrenalectomy + ALDO (40 micro g/kg per d, subcutaneousl
75 of GC receptor epidermal knockout mice with adrenalectomy allowed for the distinction between local
77 me of patients with stage I ACC treated with adrenalectomy alone; (2) to describe the outcome of stag
79 n muscle is sufficient to induce catabolism, adrenalectomy also blocks the atrophy program in respons
82 erone producing adenoma (APA) that underwent adrenalectomy and 25 patients with essential hypertensio
83 The present study determined the effect of adrenalectomy and 5alpha-reductase type-1/type-2 enzyme
85 nd the amygdala and the effects of 7 days of adrenalectomy and corticosteroid replacement upon CART e
87 ion of fetal plasma cortisol levels by fetal adrenalectomy and exogenous cortisol infusion, using RNa
89 ose who were candidates for MVR with en bloc adrenalectomy and had no preexisting adrenal impairment
94 animals exposed to fox odor after bilateral adrenalectomy and replacement with low levels of the end
95 y resected > 200 cc or > 100 g) treated with adrenalectomy and retroperitoneal lymph node dissection;
96 ylase deficiency who had undergone bilateral adrenalectomy and specimens obtained at autopsy from eig
97 d by (i) endogenous glucocorticoid ablation (adrenalectomy) and (ii) pharmacological glucocorticoid r
98 l intervention (adenectomy rather than total adrenalectomy) and the residual left sided adrenal tissu
99 to one of four groups: SHAM, adrenalectomy, adrenalectomy + Ang II (25 ng/min, subcutaneously), or a
102 hile the safety and efficacy of laparoscopic adrenalectomy are relatively well documented, few studie
103 ation in males and the behavioral effects of adrenalectomy are reversed by corticosterone replacement
104 the residual hormone seen in the brain after adrenalectomy, are suggestive evidence for a local origi
105 reasingly considered in lieu of laparoscopic adrenalectomy as robotic systems further disseminate and
106 patients undergoing laparoscopic unilateral adrenalectomies at the authors' medical institutions wer
107 s were excluded because they did not receive adrenalectomy at the time of surgery and 2 because they
108 d Pheochromocytoma) who underwent unilateral adrenalectomy at the University Hospital Galway, Ireland
110 The increase in ALC could be inhibited by adrenalectomy, beta2-adrenergic blockade using ICI 118,5
111 ients underwent 546 consecutive laparoscopic adrenalectomies between April 22, 1993, and October 21,
112 included 360 patients with uPA who underwent adrenalectomy between 2012 and 2017, 191 (53.1%) of whom
114 icoid receptor binding to the Sgk1 promoter; adrenalectomy blocked ethanol induction of Sgk1 mRNA; an
117 ective advantages compared with laparoscopic adrenalectomy, but no objective superiority has been dem
118 the effect of repeated stress was blocked by adrenalectomy, but not by adrenal medullae denervation,
119 One hundred of 169 (59.1%) were assigned to adrenalectomy by the multidisciplinary team; primary out
125 h Cushing's syndrome who underwent bilateral adrenalectomy comparing the posterior or anterior operat
128 al venous sampling who had undergone a total adrenalectomy, consecutively included from 12 referral c
129 a GR intronic sequence was also increased by adrenalectomy, consistent with increased gene transcript
134 e-period odor-shock-induced preferences; (b) adrenalectomy developmentally extends the sensitive peri
135 tic effects of DHEA-S, suggesting that, like adrenalectomy, DHEA-S exerted its effect by interfering
136 not immediately after conditioning, and like adrenalectomy, DHEA-S had no effect on auditory-cue fear
143 atabase of adrenalectomy patients, excluding adrenalectomies due to tumor extension or for palliation
148 To assess if reversal of obese phenotype by adrenalectomy entails normalization of hypothalamic gene
149 pression of hepatic markers was prevented by adrenalectomy, establishing a direct role for glucocorti
150 opic approach is the procedure of choice for adrenalectomy except in the case of invasive carcinoma o
151 is mediated by corticosteroids we performed adrenalectomy experiments in db/db and wild-type mice.
153 s evaluate the effectiveness of laparoscopic adrenalectomy for a variety of endocrine disorders.
157 enal venous sampling is recommended prior to adrenalectomy for all patients with hyperaldosteronism;
158 9 patients treated by bilateral laparoscopic adrenalectomy for Cushing's disease from 1994 to 2004.
159 orbidity in 48 patients undergoing bilateral adrenalectomy for Cushing's disease through either the a
160 hnique in most patients undergoing bilateral adrenalectomy for Cushing's syndrome without other contr
161 Several small studies have reported that an adrenalectomy for isolated adrenal metastasis in non-sma
166 n was to assess the outcomes of laparoscopic adrenalectomy for pheochromocytomas in the largest study
167 eview studies on the outcome of laparoscopic adrenalectomy for primary adrenal cancer as well as stud
168 ry reports now demonstrate that laparoscopic adrenalectomy for primary adrenal malignancy can provide
169 ved using data on 100 patients who underwent adrenalectomy for primary aldosteronism at one tertiary
172 t study was performed of patients undergoing adrenalectomy for secondary malignancy (2002-2015) at 6
175 imally invasive alternative to AVS and total adrenalectomy for the treatment of APAs in the left adre
176 EUS-RFA appears a safe alternative to total adrenalectomy for the treatment of left-sided APAs and h
177 al and biochemical outcomes and follow-up of adrenalectomy for unilateral primary aldosteronism and a
178 ensus criteria for outcomes and follow-up of adrenalectomy for unilateral primary aldosteronism.
180 with a synchronous metastasis who underwent adrenalectomy had a shorter median overall survival than
181 We excluded patients who underwent surgical adrenalectomy, had a previous cardiovascular event, were
184 eloping adrenal insufficiency (AI) following adrenalectomy has been insufficiently studied in the con
189 the robot to extend traditional laparoscopic adrenalectomy have been highlighted in recent studies.
190 my and limited comparisons with laparoscopic adrenalectomy have shown that robotic adrenalectomy is w
192 is, extra-adrenal oligometastatic disease at adrenalectomy (HR: 1.74, P = 0.031), and incomplete rese
194 ver, removal of systemic glucocorticoids, by adrenalectomy in animal models or adrenal insufficiency
195 f the prevalence and clinical outcomes after adrenalectomy in APA patients harboring CTNNB1 mutations
196 teronism and hyperplasia requiring bilateral adrenalectomy in childhood for blood pressure control.
197 rs review their experience with laparoscopic adrenalectomy in patients with benign adrenal neoplasms.
199 Laparoscopic adrenalectomy is replacing open adrenalectomy in some medical centers as the standard su
200 d inhibit estrogen production, and bilateral adrenalectomy in the most severely affected patients.
202 Removal of circulating glucocorticoids (adrenalectomy) increased GR mRNA expression in CA1 and d
206 ectomy remains the standard of care, robotic adrenalectomy is an acceptable option in high volume rob
207 ith MACS who are most likely to benefit from adrenalectomy is challenging, as adrenalectomy results i
215 scopic adrenalectomy have shown that robotic adrenalectomy is well tolerated and effective with subje
221 cts of conditioning length, cocaine dose and adrenalectomy on cocaine CPP in male and female rats.
222 linical trials demonstrating the efficacy of adrenalectomy on comorbidities associated with MACS.
223 a-THP levels but also reversed the effect of adrenalectomy on ethanol-induced loss of righting reflex
224 rom the Cox model suggest a strong effect of adrenalectomy on lowering mortality (HR = 0.23 with resi
227 a (ie, unilateral or bilateral operations as adrenalectomy or adrenal-sparing surgery, and as open or
228 ased on patient characteristics and includes adrenalectomy or conservative follow-up with treatment o
230 ent on adrenal gland-derived epinephrine, as adrenalectomy or inhibition of epinephrine production el
231 same magnitude increase in BK-induced PE as adrenalectomy or ovariectomy, suggesting that the adrena
232 .49 [95% CI, 2.33-2.67]), minimally invasive adrenalectomy (OR, 1.93 [95% CI, 1.34-2.77]), thyroid lo
235 ortant to avoid bleeding during laparoscopic adrenalectomy, particularly in patients with large tumor
236 ctively maintained institutional database of adrenalectomy patients, excluding adrenalectomies due to
237 2) adrenalectomy plus dexamethasone, and (3) adrenalectomy plus dexamethasone and spironolactone.
238 tomized rats were prepared: (1) vehicle, (2) adrenalectomy plus dexamethasone, and (3) adrenalectomy
239 and prevention of this increase (by means of adrenalectomy plus low-dose corticosterone replacement)
240 ents from rats that underwent adrenalectomy, adrenalectomy plus replacement with a physiologic dose o
242 Abolition of this cortisol surge by fetal adrenalectomy prevented both the activation of exon 1A e
243 Abolition of this cortisol surge by fetal adrenalectomy prevented the prepartum fall in muscle IGF
244 etastases to the adrenal gland, laparoscopic adrenalectomy provides equivalent oncologic outcomes to
249 ytoma, claim thousands of lives yearly; yet, adrenalectomy remains underused despite its lifesaving p
250 sampling [AVS]) and removal (by laparoscopic adrenalectomy) require invasive procedures that are unat
251 patients undergoing unilateral laparoscopic adrenalectomy required conversion to open adrenalectomy.
252 hypothalamus, or metyrapone-induced chemical adrenalectomy rescued the impaired glucose homeostasis o
253 al of circulating glucocorticoids in mice by adrenalectomy resulted in the rapid onset of spontaneous
254 enefit from adrenalectomy is challenging, as adrenalectomy results in improvement of cardiovascular m
255 netically obese leptin-deficient ob/ob mice, adrenalectomy reverses or attenuates the obese phenotype
259 Extracorporeal membrane oxygenation and adrenalectomy should be considered as a therapeutic in m
260 These factors suggest that laparoscopic adrenalectomy should be the preferential surgical techni
261 reover, rats exposed to the context prior to adrenalectomy showed normal long-term contextual-fear co
267 euvers, variation during the circadian peak, adrenalectomy, social defeat and acute injections of alc
268 both adrenal specimens for the 11 bilateral adrenalectomy specimens was 28-297 g, with a mean weight
270 1 patients who underwent posterior bilateral adrenalectomy suffered from chronic back pain, compared
271 asive general surgery have made laparoscopic adrenalectomy the method of choice for removing adrenal
272 enal hyperplasia who had undergone bilateral adrenalectomy, the formation of the adrenal medulla was
274 ual glucocorticoid secretion, because, after adrenalectomy, these levels do not undergo the normal in
275 sual time of death at 5 weeks; a month after adrenalectomy, they exhibited normal levels of pituitary
276 as it increases in both KO and WT mice after adrenalectomy; this increase is reversed by glucocortico
277 comes have been comparable with laparoscopic adrenalectomy though there have been no randomized contr
281 CT) in surgical planning before laparoscopic adrenalectomy was evaluated in a retrospective study.
282 In this study, AI after MVR with en bloc adrenalectomy was frequent, even in patients with adequa
287 Mice rendered glucocorticoid deficient by adrenalectomy were more susceptible than intact mice to
289 assistance has also enabled cortical-sparing adrenalectomy which may obviate the need for steroid hor
293 lated phaeochromocytoma continues to rely on adrenalectomies with their associated Addisonian-like co
295 chronic (21 day) restraint stress (CRS) and adrenalectomy with hormone replacement with the selectiv
296 ing activity was observed when pharmacologic adrenalectomy with mitotane was done in combination with
297 stigated showed altered expression following adrenalectomy with or without low/high-dose corticostero
298 per group) received either sham or bilateral adrenalectomy (with CORT replacement in their drinking w
300 Most patients derive clinical benefit from adrenalectomy, with younger patients and female patients